𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acceptance of tamoxifen chemoprevention by physicians and women at risk

✍ Scribed by Andrew McKay; Steve Latosinsky; Wanda Martin


Book ID
102105464
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
57 KB
Volume
103
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Acceptance of tamoxifen chemoprevention
✍ Julia Tchou; Nanjiang Hou; Alfred Rademaker; V. Craig Jordan; Monica Morrow πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 79 KB

## Abstract ## BACKGROUND In the National Surgical Adjuvant Breast and Bowel Project (NSABP) P‐1 trial, tamoxifen was shown to reduce breast carcinoma risk by 49% in high‐risk women. The purpose of the current study was to identify factors associated with being offered, and accepting, tamoxifen ch

Identification of a chemoprevention coho
✍ Carol J. Fabian; Sahar Kamel; Carola Zalles; Bruce F. Kimler πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 935 KB

In a prospective pilot study, we performed breast fine needle aspirations (FNAs) on 21 3 high-risk and 30 low-risk women and analyzed these aspirates for cytologic changes and biomarker abnormalities of aneuploidy and overexpressed estrogen receptor (ER), epidermal growth factor receptor (ECFR), p53